Viral Hive Knowledge: Twitter, Historians, and Coronavirus/COVID-19

We are all historians of the present. At least we should be. Many fellow historians of knowledge are currently using a wide variety of media to share their experience and research in an effort to put the global response to the COVID-19 pandemic into context. Twitter is one medium where this conversation is especially lively, as Eileen Sperry has noted on Nursing Clio, a wonderful group blog that is also active on Twitter. One can find these parts of Twitter by searching for the relevant hashtags, for example, #histmed (history of medicine) and the much more generic #twitterstorians (historians on twitter).

Continue reading “Viral Hive Knowledge: Twitter, Historians, and Coronavirus/COVID-19”

CfP: Global Knowledge, Global Legitimacy? Transatlantic Biomedicine since 1970

Washington, DC, Sept. 6-7, 2019
Application deadine: Dec. 15, 2018

When the French pharmaceutical company Roussell Uclaff, a subsidiary of the German chemical giant Hoechst AG, was ready to introduce an abortion pill in 1988, American activists flooded the company’s headquarters near Frankfurt with protest letters. In response, the company’s German CEO mandated to stop the project. But the French state, a Hoechst minority shareholder, took the idea across the border, patented it, and embarked on medical trials for the new product in France. Ten years later, scientists in the United States successfully isolated human embryonic stem cells. The country’s regulatory framework had left them free to let the cells proliferate indefinitely. But researchers adopted concepts implemented in Britain to limit the cells’ growth to 13 days after gestation.

Continue reading→